Search results
Results From The WOW.Com Content Network
Aid Access is a nonprofit organization that provides access to medication abortion by mail to the United States and worldwide. It describes its work as a harm reduction strategy designed to provide safe access to mifepristone and misoprostol for those able to become pregnant in the United States who may not otherwise have access to abortion or miscarriage management services. [2]
During a news conference at his Mar-a-Lago resort on Thursday, former President Donald Trump would not rule out revoking access to mifepristone, one of the two drugs used in medication abortions.
[159] [160] [161] Even so, several states in the US require providers of non-surgical abortion who use mifepristone to tell patients that reversal is an option. [162] In 2019, researchers initiated a small trial of the so-called "reversal" regimen using mifepristone followed by progesterone or placebo.
Mifepristone is used as part of a two-drug FDA-approved regimen for the majority of abortions nationwide. The case is a major test for the conservative-majority court, which in 2022 overturned Roe v.
In 2000, GenBioPro's generic version of mifepristone was approved for medication abortion, as part of a two-drug regimen in combination with misoprostol. In 2023, GenBioPro sued the FDA to obtain a legal judgement confirming that mifepristone could continue to be sold, in spite of anti-abortion laws passed in some states.
Mifepristone was developed in 1980 and came into use in France in 1987. [16] It became available in the United States in 2000, for medication abortion, and in 2010, for Cushing's syndrome. [17] [10] [12] It is on the World Health Organization's List of Essential Medicines. [18] Mifepristone was approved in Canada in January 2017. [19] [20]
Mifepristone was approved by the Food and Drug Administration (FDA) in September 2000. [2] Medication abortion accounts for over half of all abortions in the United States. [3] Under the 2000 approval, mifepristone was approved by the FDA under Congressional regulations granted to them by Subpart H of the FDA's mandate.
California, Colorado, Maine, Massachusetts, New York, Vermont and Washington have passed laws to also protect telehealth actions when the provider prescribes abortion pills to a patient who is in an antiabortion state. [1] These shield laws have been enacted after the United States Supreme Court overturned Roe v. Wade with Dobbs in June 2022 ...